Thierry Calandra

Active 1988–2026

159
Papers
60,038
Citations
109
h-index
154
i10-index

Citations

Citations per year for Thierry Calandra1936: 2 citations1989: 6 citations1990: 5 citations1991: 25 citations1992: 26 citations1993: 28 citations1994: 30 citations1995: 61 citations1996: 90 citations1997: 135 citations1998: 165 citations1999: 120 citations2000: 193 citations2001: 199 citations2002: 250 citations2003: 399 citations2004: 233 citations2005: 353 citations2006: 322 citations2007: 317 citations2008: 387 citations2009: 545 citations2010: 620 citations2011: 608 citations2012: 570 citations2013: 667 citations2014: 503 citations2015: 420 citations2016: 436 citations2017: 358 citations2018: 287 citations2019: 1,282 citations2020: 1,250 citations2021: 1,171 citations2022: 837 citations2023: 649 citations2024: 1,146 citations2025: 564 citations2026: 25 citations1937–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,826 citing papers, 21.6% of this breakdownChina: 1,241 citing papers, 7% of this breakdownGermany: 1,091 citing papers, 6.2% of this breakdownUnited Kingdom: 1,030 citing papers, 5.8% of this breakdownFrance: 971 citing papers, 5.5% of this breakdownItaly: 776 citing papers, 4.4% of this breakdownSpain: 668 citing papers, 3.8% of this breakdownNetherlands: 663 citing papers, 3.8% of this breakdownAustralia: 579 citing papers, 3.3% of this breakdownCanada: 556 citing papers, 3.1% of this breakdownSwitzerland: 532 citing papers, 3% of this breakdownBelgium: 476 citing papers, 2.7% of this breakdown
0%21.6%Other 29.8%

Fields

  • Medicine70.5%
  • Immunology and Microbiology15.4%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Neuroscience1.1%
  • Nursing0.9%
  • Engineering0.5%
  • Other2.5%

Topics

  • Antifungal resistance and susceptibility10.3%
  • Sepsis Diagnosis and Treatment7.5%
  • Fungal Infections and Studies7.2%
  • Immune Response and Inflammation3.5%
  • Macrophage Migration Inhibitory Factor2.7%
  • Neutropenia and Cancer Infections2.4%
  • Other66.4%

Coauthors

All papers

Open in search
  1. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher C. Kibbler, Dimitrios P. Kontoyiannis, Bart Jan Kullberg, Katrien Lagrou, Frédéric Lamoth, Thomas Lehrnbecher, Jürgen Loeffler, Olivier Lortholary, Johan Maertens, Oscar Marchetti, Kieren A. Marr, Henry Masur, Jacques F. Meis, C Orla Morrisey, Márcio Nucci, Luis Ostrosky‐Zeichner, Livio Pagano, Thomas F. Patterson, John R. Perfect, Zdeněk Ráčil, Emmanuel Roilides, Marcus Ruhnke, Cornelia Schaefer Prokop, Shmuel Shoham, Monica A. Slavin, David A. Stevens, George R. Thompson, José A. Vázquez, Claudio Viscoli, Thomas J. Walsh, Adilia Warris, L. Joseph Wheat, P. Lewis White, Theoklis E. Zaoutis, Peter G. Pappas - Clinical Infectious Diseases 2019 cited by 2,817

  2. The pathophysiology of sepsis and precision-medicine-based immunotherapy

    Authors: , , , , , , , , , , , , , , , , - Nature Immunology 2024 cited by 323

  3. Macrophage migration inhibitory factor: a regulator of innate immunity

    Authors: , - Nature reviews. Immunology 2003 cited by 1,791

  4. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theoklis E. Zaoutis, John E. Bennett - Clinical Infectious Diseases 2008 cited by 4,909

  5. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2012 cited by 1,214

  6. Sepsis: a roadmap for future research

    Authors: , , , , , , , , , , , , - The Lancet Infectious Diseases 2015 cited by 1,010

  7. Changes in the epidemiological landscape of invasive candidiasis

    Authors: , , , - Journal of Antimicrobial Chemotherapy 2017 cited by 540

  8. Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2024 cited by 122

  9. Initial antimicrobial management of sepsis

    Authors: , , , , , , , , - Critical Care 2021 cited by 175

  10. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Intensive Care Medicine 2020 cited by 454

  11. EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group

    Authors: , , , , , , , - Clinical Infectious Diseases 2021 cited by 293

  12. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

    Authors: , , , , , , , , , - Haematologica 2016 cited by 678

  13. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José A. Vázquez, Joost Wauters, Erika Asperges, Andrea Cortegiani, Cecilia Grecchi, Ilias Karaiskos, Clément Le Bihan, Toine Mercier, Klaus Leth Mortensen, Maddalena Peghin, Chiara Rebuffi, Sofía Tejada, Antonio Vena, Valentina Zuccaro, Luigia Scudeller, Thierry Calandra, Claire Roger, Christian Eckmann, Jean‐Pierre Gangneux, Esther Segal, Geoffrey W. Coombs, Andreas Voß - Intensive Care Medicine 2024 cited by 171

  14. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Intensive Care Medicine 2007 cited by 4,940

  15. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , European Society of Intensive Care Medicine, European Respiratory Society, International Sepsis Forum, Japanese Association for Acute Medicine, Japanese Society of Intensive Care Medicine, Society of Critical Care Medicine, Society of Hospital Medicine, Surgical Infection Society, World Federation of Societies of Intensive and Critical Care Medicine. - 2008 cited by 3,927

  16. ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol

    Authors: , , , , , , , , , , , , , , , , , , , - BMJ Open 2022 cited by 60

  17. Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2008 cited by 460

  18. Invasive candidiasis as a cause of sepsis in the critically ill patient

    Authors: , - Virulence 2013 cited by 378

  19. Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2019 cited by 162

  20. Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , , , , , - Clinical Infectious Diseases 2009 cited by 3,207

  21. The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit

    Authors: , - Critical Care Medicine 2005 cited by 839

  22. Risk factors for candidemia: a prospective matched case-control study

    Authors: , , , , , , , , , , , , , , , , , , , , - Critical Care 2020 cited by 182

  23. Pulmonary aspergillosis: diagnosis and treatment

    Authors: , - European Respiratory Review 2022 cited by 131

  24. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Intensive Care Medicine 2021 cited by 162